SUMITOMO PHARMA ONCOLOGY

sumitomo-pharma-oncology-logo

Sumitomo Pharma Oncology is a novelย cancer therapeutics developer. Their research includes survival mechanisms and novel protein interactions. They are committed to pursuing a diverse and purposeful pipeline that investigates drivers of treatment resistance and tumor progression.

#SimilarOrganizations #People #Website #More

SUMITOMO PHARMA ONCOLOGY

Social Links:

Industry:
Health Care Oncology Pharmaceutical Therapeutics

Founded:
2006-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.oncology.sumitomo-pharma.com

Total Employee:
51+

Status:
Active

Contact:
+1 617 674 6800

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager Font Awesome HSTS Cloudflare JS CDN JS Amazon S3


Similar Organizations

alacrity-care-logo

Alacrity Care

Alacrity Care is a technology company developing digital care companions for oncology therapeutics.

bakx-therapeutics-logo

BAKX Therapeutics

BAKX Therapeutics is a provider of cancer treatment.

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

not_available_image

Delve Therapeutics

Delve Therapeutics is investigating novel oncology therapeutics

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

longevity-biotech-logo

Longevity Biotech

Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.

nutcracker-therapeutics-logo

Nutcracker Therapeutics

Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

sionna-therapeutics-logo

Sionna Therapeutics

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

sumitomo-dainippon-pharma-oncology-logo

Sumitomo Dainippon Pharma Oncology

Sumitomo Dainippon Pharma Oncology is a developer of novel cancer therapeutics.

Current Employees Featured

not_available_image

Justin Caserta
Justin Caserta Executive Director and Head of CMC @ Sumitomo Pharma Oncology
Executive Director and Head of CMC

zhikai-zhu_image

Zhikai Zhu
Zhikai Zhu Senior Manager, CMC Project Management @ Sumitomo Pharma Oncology
Senior Manager, CMC Project Management
2022-03-01

Official Site Inspections

http://www.oncology.sumitomo-pharma.com

  • Host name: ec2-34-202-224-116.compute-1.amazonaws.com
  • IP address: 34.202.224.116
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Sumitomo Pharma Oncology"

Sumitomo Pharma America Launches as New Combined โ€ฆ

CAMBRIDGE, Mass., July 10, 2023 /PRNewswire/ โ€” Sumitomo Pharma America, Inc. (SMPA), as previously announced on April 3, 2023, is pleased to share it has successfully launched its โ€ฆSee details»

Innovative Treatments, Science and Technology | Sumitomo โ€ฆ

Dedicated to improving the health and well-being of people around the world. We drive innovative treatments, science, and technology to address patient needs in the critical areas of oncology, โ€ฆSee details»

Sumitomo Pharma Oncology Presents New Data from โ€ฆ

Apr 8, 2022 Sumitomo Pharma Oncology, Inc., is a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. As a global oncology organization with teams in the U.S. and Japan, SMP โ€ฆSee details»

Sumitomo Pharma Oncology, Inc. - MassBio

Dec 15, 2022 Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. โ€ฆSee details»

Sumitomo Dainippon Pharma Oncology - Crunchbase

Sumitomo Dainippon Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. This U.S. โ€ฆSee details»

Sumitomo Pharma Oncology - VentureRadar

Sumitomo Pharma Oncology, Inc. is a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. As a global oncology organization with teams in the U.S. and Japan, SMP Oncology is committed โ€ฆSee details»

Sumitomo Pharma Oncology, Inc. Presents Updated Preliminary โ€ฆ

Jun 12, 2023 About Sumitomo Pharma Oncology, Inc. Sumitomo Pharma Oncology, Inc. is a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. As a global oncology organiza on with โ€ฆSee details»

Sumitomo Dainippon Pharma Oncology Presents New Data from โ€ฆ

Inhibitor TP-5809 and CDK9 inhibitor alvocidib. Additionally, Sumitomo Dainippon Pharma Co., Ltd., the parent company of Sumitomo Dainippon Pharma Oncology (SDP Oncology), โ€ฆSee details»

New Expanded Scale, Resources Capabilities - Sumitomo Pharma

Jul 11, 2023 Jatin Shah, Chief Oncology Development Officer of Sumitomo Pharma America, added, "SMPA is uniquely positioned with a strong internal discovery and translational โ€ฆSee details»

Sumitomo Pharma Oncology, Inc. Profile - Medical XPRT

Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with โ€ฆSee details»

Sumitomo Pharma Subsidiary Companies in the U.S., Including โ€ฆ

Apr 3, 2023 Sumitomo Pharma Oncology, Inc. is a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. As a global oncology organization with teams in the U.S. and Japan, SMP โ€ฆSee details»

Sumitomo Pharma Subsidiary Companies in the U.S., Including โ€ฆ

Apr 3, 2023 Sumitomo Pharma Oncology, Inc. is a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. As a global oncology organization with teams in the U.S. and Japan, SMP โ€ฆSee details»

Member Spotlight: Q&A with Sumitomo Dainippon โ€ฆ

Feb 1, 2022 Sumitomo Dainippon Pharma Oncology, Inc. (SDP Oncology) is based in the U.S. and a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. How do your organizationโ€™s activities help patients now and into the โ€ฆSee details»

Sumitomo Pharma Oncology - Crunchbase Company Profile

Sumitomo Pharma Oncology is a developer of novel cancer therapeutics.See details»

Sumitomo Pharma Oncology Presents New Data from ... - MassBio

Sumitomo Pharma Oncology, Inc., is a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. As a global oncology organization with teams in the U.S. and Japan, SMP Oncology is โ€ฆSee details»

Sumitomo Pharma Presents Urology and Oncology Data at AUA โ€ฆ

May 7, 2024 About Sumitomo Pharma Sumitomo Pharma Co., Ltd. is a global pharmaceutical company based in Japan with key operations in the U.S. (Sumitomo Pharma America, Inc.), โ€ฆSee details»

Sumitomo Pharma Oncology Presents Preliminary Data from โ€ฆ

Dec 10, 2022 Sumitomo Pharma Oncology, Inc. is a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. As a global oncology organization with teams in the U.S. and Japan, SMP โ€ฆSee details»

Sumitomo Pharma America to Present Preliminary Clinical Data โ€ฆ

Nov 3, 2023 Sumitomo Pharma America to Present Preliminary Clinical Data Evaluating Investigational Oncology Agents TP-3654 and DSP-5336 at the American Society of โ€ฆSee details»

Director, Medical Affairs Strategy (Hematology/Oncology)

Feb 26, 2025 Sumitomo Pharma Co., Ltd. is a global pharmaceutical company based in Japan with key operations in the U.S. (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma โ€ฆSee details»

Activity and safety of atezolizumab plus carboplatin and paclitaxel โ€ฆ

Thymic epithelial tumours, including thymoma and thymic carcinoma, are rare and develop from the thymus located in the anterior mediastinum, with an incidence rate of 0·15 per 100 000 โ€ฆSee details»

linkstock.net © 2022. All rights reserved